Literature DB >> 28966054

Norovirus Cell Tropism Is Determined by Combinatorial Action of a Viral Non-structural Protein and Host Cytokine.

Sanghyun Lee1, Craig B Wilen1, Anthony Orvedahl2, Broc T McCune1, Ki-Wook Kim1, Robert C Orchard1, Stefan T Peterson3, Timothy J Nice4, Megan T Baldridge5, Herbert W Virgin6.   

Abstract

Cellular tropism during persistent viral infection is commonly conferred by the interaction of a viral surface protein with a host receptor complex. Norovirus, the leading global cause of gastroenteritis, can be persistently shed during infection, but its in vivo cellular tropism and tropism determinants remain unidentified. Using murine norovirus (MNoV), we determine that a small number of intestinal epithelial cells (IECs) serve as the reservoir for fecal shedding and persistence. The viral non-structural protein NS1, rather than a viral surface protein, determines IEC tropism. Expression of NS1 from a persistent MNoV strain is sufficient for an acute MNoV strain to target IECs and persist. In addition, interferon-lambda (IFN-λ) is a key host determinant blocking MNoV infection in IECs. The inability of acute MNoV to shed and persist is rescued in Ifnlr1-/- mice, suggesting that NS1 evades IFN-λ-mediated antiviral immunity. Thus, NS1 and IFN-λ interactions govern IEC tropism and persistence of MNoV.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  interferon-lambda; norovirus; persistence; reservoir; tropism

Mesh:

Substances:

Year:  2017        PMID: 28966054      PMCID: PMC5679710          DOI: 10.1016/j.chom.2017.08.021

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  60 in total

1.  Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype.

Authors:  M Bens; A Bogdanova; F Cluzeaud; L Miquerol; S Kerneis; J P Kraehenbuhl; A Kahn; E Pringault; A Vandewalle
Journal:  Am J Physiol       Date:  1996-06

2.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

3.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

Review 4.  Capturing norovirus transmission.

Authors:  Miranda de Graaf; Nele Villabruna; Marion Pg Koopmans
Journal:  Curr Opin Virol       Date:  2017-01-02       Impact factor: 7.090

5.  A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence.

Authors:  Timothy J Nice; David W Strong; Broc T McCune; Calvin S Pohl; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

6.  Antibody is critical for the clearance of murine norovirus infection.

Authors:  Karen A Chachu; David W Strong; Anna D LoBue; Christiane E Wobus; Ralph S Baric; Herbert W Virgin
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

7.  Natural history of human calicivirus infection: a prospective cohort study.

Authors:  Barry Rockx; Matty De Wit; Harry Vennema; Jan Vinjé; Erwin De Bruin; Yvonne Van Duynhoven; Marion Koopmans
Journal:  Clin Infect Dis       Date:  2002-07-10       Impact factor: 9.079

8.  Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells.

Authors:  Mariam B Gonzalez-Hernandez; Thomas Liu; Hilary C Payne; Jennifer E Stencel-Baerenwald; Mine Ikizler; Hideo Yagita; Terence S Dermody; Ifor R Williams; Christiane E Wobus
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

Review 9.  Human norovirus transmission and evolution in a changing world.

Authors:  Miranda de Graaf; Janko van Beek; Marion P G Koopmans
Journal:  Nat Rev Microbiol       Date:  2016-05-23       Impact factor: 60.633

10.  Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.

Authors:  Timothy J Nice; Lisa C Osborne; Vesselin T Tomov; David Artis; E John Wherry; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2016-06-21       Impact factor: 6.823

View more
  38 in total

1.  Persistence of Systemic Murine Norovirus Is Maintained by Inflammatory Recruitment of Susceptible Myeloid Cells.

Authors:  Jacob A Van Winkle; Bridget A Robinson; A Mack Peters; Lena Li; Ruth V Nouboussi; Matthias Mack; Timothy J Nice
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

2.  A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.

Authors:  Sanghyun Lee; Hejun Liu; Craig B Wilen; Zoi E Sychev; Chandni Desai; Barry L Hykes; Robert C Orchard; Broc T McCune; Ki-Wook Kim; Timothy J Nice; Scott A Handley; Megan T Baldridge; Gaya K Amarasinghe; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2019-05-23       Impact factor: 21.023

3.  Tropism for tuft cells determines immune promotion of norovirus pathogenesis.

Authors:  Craig B Wilen; Sanghyun Lee; Leon L Hsieh; Robert C Orchard; Chandni Desai; Barry L Hykes; Michael R McAllaster; Dale R Balce; Taylor Feehley; Jonathan R Brestoff; Christina A Hickey; Christine C Yokoyama; Ya-Ting Wang; Donna A MacDuff; Darren Kreamalmayer; Michael R Howitt; Jessica A Neil; Ken Cadwell; Paul M Allen; Scott A Handley; Menno van Lookeren Campagne; Megan T Baldridge; Herbert W Virgin
Journal:  Science       Date:  2018-04-13       Impact factor: 47.728

4.  Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response.

Authors:  Stefan T Peterson; Elizabeth A Kennedy; Pamela H Brigleb; Gwen M Taylor; Kelly Urbanek; Traci L Bricker; Sanghyun Lee; Haina Shin; Terence S Dermody; Adrianus C M Boon; Megan T Baldridge
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

5.  Characterizing a Murine Model for Astrovirus Using Viral Isolates from Persistently Infected Immunocompromised Mice.

Authors:  Valerie Cortez; Bridgett Sharp; Jiangwei Yao; Brandi Livingston; Peter Vogel; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

6.  A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.

Authors:  Scott Sherrill-Mix; Kaleigh Connors; Grace M Aldrovandi; Jason M Brenchley; Charles Boucher; Frederic D Bushman; Ronald G Collman; Satya Dandekar; Nichole R Klatt; Laurel A Lagenaur; Roger Paredes; Gilda Tachedjian; Jim A Turpin; Alan L Landay; Mimi Ghosh
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-07       Impact factor: 2.205

7.  Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo.

Authors:  Lucy Thorne; Jia Lu; Yasmin Chaudhry; Dalan Bailey; Ian Goodfellow
Journal:  J Gen Virol       Date:  2018-04-23       Impact factor: 3.891

8.  Lack of Effect of Murine Norovirus Infection on the CD4+ CD45RBhigh T-cell Adoptive Transfer Mouse Model of Inflammatory Bowel Disease.

Authors:  Charlie C Hsu; Karuna Patil; Audrey Seamons; Thea L Brabb; Piper M Treuting; Jisun Paik; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2020-01-14       Impact factor: 0.982

Review 9.  The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus.

Authors:  Timothy J Nice; Bridget A Robinson; Jacob A Van Winkle
Journal:  Trends Microbiol       Date:  2017-11-17       Impact factor: 17.079

10.  CD300lf Conditional Knockout Mouse Reveals Strain-Specific Cellular Tropism of Murine Norovirus.

Authors:  Vincent R Graziano; Mia Madel Alfajaro; Cameron O Schmitz; Renata B Filler; Madison S Strine; Jin Wei; Leon L Hsieh; Megan T Baldridge; Timothy J Nice; Sanghyun Lee; Robert C Orchard; Craig B Wilen
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.